News
A psychedelic nasal spray requiring a much shorter period of clinical supervision has shown promise against ...
As respiratory illnesses like COVID-19, influenza, and Mycoplasma pneumonia continue to spread, the need for safe, ...
MomMed, a trusted maternal and family wellness brand, today announced a strategic partnership with nasal care innovator ...
BPL-003 showed “robust” efficacy data in treatment-resistant depression, according to analysts from Jefferies, who noted that the asset could hit peak market sales of $1 billion. The results clear the ...
Atai Life Sciences NV shares climbed after a psychedelic nasal spray from Beckley Psytech Ltd, the company it plans to ...
Positive study results in Phase 2 lead to a green light for the companies’ combination and plans to move their nasal spray ...
A new study found that almost all plans in 40 states and Washington, DC covered at least one form of the opioid overdose ...
Milestone® Pharmaceuticals Inc. (Nasdaq: MIST) today announced submission of its response to the U.S. Food and Drug Administration (FDA)’s Complete Response Letter (CRL) regarding its New Drug ...
Vending machines throughout Denver have distributed more than 1,800 free boxes of the overdose reversal medication naloxone ...
ARS Pharma has claimed FDA approval for its epinephrine nasal spray neffy, becoming the first needle-free alternative to EpiPen-style autoinjectors for serious allergic reactions. The green light ...
The potent synthetic opioid, developed for large animals, threatens to reverse Michigan's recent progress in reducing ...
An alternative to epinephrine autoinjectors that can be delivered by a nasal spray has been launched in Germany, its first ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results